Investors in Amgen Inc. AMGNneed to pay close attention to the stock based on moves in the options market lately. That is because the March 2nd, 2017 $170 Call had some of the highest implied volatility of all equity options today. What is …
co will make upfront payment of $40 million and purchase $20 million of cytomx common stock.CytomX will be eligible to receive up to $455 million in development, regulatory and commercial milestones for EGFR program.CytomX to be able …
Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …
We expect shares to trade off on the elevated expenses though the stock market was arguably prepared for it with ... and 3.8% dividend yield. Amgen (AMGN): Reiterate outperform rating. Remain buyers after a solid fourth quarter beat and …
Of the six analysts covering Atara Biotherapeutics in January 2018, four analysts have given the stock a “buy” or a higher rating, while two analysts have given it a “hold” rating. By comparison, of the 26 analysts covering Amgen (AMGN) in …
SPONSORED: 10 stocks we like better than Amgen When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter …
On Sunday, the world's largest independent biotechnology company, Amgen Inc. (Nasdaq: AMGN), bought Onyx Pharmaceuticals Inc. (Nasdaq: ONXX) in a $10.4 billion dollar deal – making it the fifth-largest biotech deal in history …
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Amgen (NASDAQ: AMGN) and …